BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $162,360 | -4.2% | 53,408 | +3.7% | 0.00% | 0.0% |
Q2 2023 | $169,468 | +7.1% | 51,510 | +3.5% | 0.00% | 0.0% |
Q1 2023 | $158,192 | -41.8% | 49,746 | +26.7% | 0.00% | -50.0% |
Q4 2022 | $271,776 | +17.1% | 39,274 | +7.1% | 0.00% | 0.0% |
Q3 2022 | $232,000 | +66.9% | 36,665 | +9.5% | 0.00% | +100.0% |
Q2 2022 | $139,000 | -14.7% | 33,488 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $163,000 | -54.6% | 33,535 | -6.6% | 0.00% | -50.0% |
Q4 2021 | $359,000 | -49.2% | 35,895 | -2.9% | 0.00% | -50.0% |
Q3 2021 | $706,000 | -41.7% | 36,969 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $1,210,000 | +3566.7% | 37,847 | +3337.5% | 0.00% | – |
Q1 2021 | $33,000 | -37.7% | 1,101 | -9.5% | 0.00% | – |
Q4 2020 | $53,000 | -20.9% | 1,217 | -2.6% | 0.00% | – |
Q3 2020 | $67,000 | -13.0% | 1,250 | -0.6% | 0.00% | – |
Q2 2020 | $77,000 | +87.8% | 1,258 | +40.2% | 0.00% | – |
Q1 2020 | $41,000 | -46.1% | 897 | +3.9% | 0.00% | – |
Q4 2019 | $76,000 | -7.3% | 863 | -3.3% | 0.00% | – |
Q3 2019 | $82,000 | -27.4% | 892 | 0.0% | 0.00% | – |
Q2 2019 | $113,000 | -37.6% | 892 | -22.5% | 0.00% | -100.0% |
Q1 2019 | $181,000 | +53.4% | 1,151 | -3.4% | 0.00% | – |
Q4 2018 | $118,000 | -32.2% | 1,191 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $174,000 | -1.1% | 1,191 | +6.0% | 0.00% | 0.0% |
Q2 2018 | $176,000 | -96.7% | 1,124 | -96.4% | 0.00% | -94.7% |
Q1 2018 | $5,342,000 | -9.0% | 31,285 | -5.1% | 0.02% | 0.0% |
Q4 2017 | $5,872,000 | +42.1% | 32,968 | +9.6% | 0.02% | +26.7% |
Q3 2017 | $4,131,000 | +54.6% | 30,075 | +18.2% | 0.02% | +50.0% |
Q2 2017 | $2,672,000 | +19.2% | 25,438 | +3.2% | 0.01% | +25.0% |
Q1 2017 | $2,241,000 | +70.5% | 24,650 | +15.7% | 0.01% | +60.0% |
Q4 2016 | $1,314,000 | -99.9% | 21,304 | -0.3% | 0.01% | -16.7% |
Q3 2016 | $1,447,781,000 | +56.8% | 21,360 | +0.2% | 0.01% | +50.0% |
Q2 2016 | $923,289,000 | +1342.6% | 21,328 | +1328.5% | 0.00% | – |
Q1 2016 | $64,000,000 | -87.1% | 1,493 | -80.8% | 0.00% | -100.0% |
Q4 2015 | $498,000,000 | +208268.2% | 7,758 | +178.2% | 0.00% | +100.0% |
Q3 2015 | $239,000 | -99.9% | 2,789 | +8.0% | 0.00% | -50.0% |
Q2 2015 | $434,732,000 | -76.9% | 2,582 | -83.4% | 0.00% | -75.0% |
Q1 2015 | $1,881,114,000 | +32.9% | 15,576 | +1.0% | 0.01% | +33.3% |
Q4 2014 | $1,414,965,000 | +178.4% | 15,427 | +8.9% | 0.01% | +200.0% |
Q3 2014 | $508,204,000 | +5.7% | 14,164 | +13.6% | 0.00% | 0.0% |
Q2 2014 | $480,929,000 | +355.3% | 12,469 | +168.4% | 0.00% | – |
Q1 2014 | $105,627,000 | +11.1% | 4,645 | +2.5% | 0.00% | – |
Q4 2013 | $95,102,000 | – | 4,533 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
RA Capital Management | 167,367 | $14,318,000 | 2.06% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |